Expenses
Net expenses totaled $3.7 million and $1.8 million, respectively, for the three months ended March 31, 2018 and 2017, of which $1.7 million and $1.0 million, respectively, were gross base management fees and gross performance-based incentive fees and $1.6 million and $0.8 million, respectively, were interest and other credit facility expenses. Over the same periods, $0.0 million and $0.8 million, respectively, of base management fees were waived and $0.3 million and $0.1 million, respectively, of performance-based incentive fees were waived. Administrative services and other general and administrative expenses totaled $0.7 million and $0.8 million, respectively, for the three months ended March 31, 2018 and 2017. Expenses generally consist of management fees, performance-based incentive fees, administrative services expenses, insurance, legal expenses, directors’ expenses, audit and tax expenses, transfer agent fees and expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. For the three month periods, the increase in net expenses year over year is primarily due to higher interest, incentive and management fee expense on a larger, higher yielding portfolio as compared to the year ago period.
Net Investment Income
The Company’s net investment income totaled $5.6 million and $5.6 million, or $0.35 and $0.35, per average share, respectively, for the three months ended March 31, 2018 and 2017.
Net Realized Gain
The Company had investment sales and prepayments totaling approximately $26.0 million and $55.8 million, respectively, for the three months ended March 31, 2018 and 2017. Net realized gains (losses) over the same periods were $(0.0) million and $0.1 million, respectively. Net realized losses for the three months ended March 31, 2018 were de minimis. Net realized gains for the three months ended March 31, 2017 were primarily related to partial or complete sales of select investments.
Net Change in Unrealized Gain (Loss)
For the three months ended March 31, 2018 and 2017, net change in unrealized gain (loss) on the Company’s assets and liabilities totaled $(0.1) million and $0.2 million, respectively. Net unrealized loss for the three months ended March 31, 2018 is primarily due to depreciation in the value of our investments in Metamorph US 3, LLC, First Lien Loan Program LLC and PPT Management Holdings, LLC, among others, partially offset by appreciation in NorthMill LLC, Trident USA Health Services and Anesthesia Consulting & Management, LP, among others. Net unrealized gain for the three months ended March 31, 2017 is primarily due to appreciation in the value of our investments in Securus Technologies, TwentyEighty, Inc. and American Teleconferencing Services, Inc., among others, partially offset by depreciation in Metamorph US 3, LLC, Aegis Toxicology Sciences Corporation and nThrive, Inc., among others.
Net Increase in Net Assets From Operations
For the three months ended March 31, 2018 and 2017, the Company had a net increase in net assets resulting from operations of $5.5 million and $5.9 million, respectively. For the same periods, earnings per average share were $0.34 and $0.37, respectively.
LIQUIDITY AND CAPITAL RESOURCES
The Company’s liquidity and capital resources are generally available through its Credit Facility, through periodicfollow-on equity offerings, as well as from cash flows from operations, investment sales andpre-payments of investments. At March 31, 2018, the Company had $140.4 million in borrowings outstanding on its Credit Facility and $59.6 million of unused capacity, subject to borrowing base limits.
52